General MedicationsTOPICALGeneric
FUNGIZONE
AMPHOTERICIN B
Standard Dose
3%
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary
Approval overview FUNGIZONE is listed in Drugs@FDA under application 050313 (NDA).
Marketing status: Discontinued Active ingredient AMPHOTERICIN B Form and strength OINTMENT;TOPICAL - 3% Sponsor APOTHECON Submission history Latest submission status date: 1997-06-25 00:00:00.
Structured Monograph
Clinical summary
Approval overview FUNGIZONE is listed in Drugs@FDA under application 050313 (NDA). Marketing status: Discontinued Active ingredient AMPHOTERICIN B Form and strength OINTMENT;TOPICAL - 3% Sponsor APOTHECON Submission history Latest submission status date: 1997-06-25 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Discontinued
Interaction Notes
- No interaction notes stored yet.